Neutralization of PD-L2 is Essential for Overcoming Immune Checkpoint Blockade Resistance in Ovarian Cancer. (2021)
Attributed to:
Manipulation of the Complement Pathway to Increase Radiation Sensitivity and Immune Response
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-20-0482
PubMed Identifier: 34011561
Publication URI: http://europepmc.org/abstract/MED/34011561
Type: Journal Article/Review
Volume: 27
Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research
Issue: 15
ISSN: 1078-0432